Annual Shareholders Equity
$52.09 M
-$36.65 M-41.30%
December 31, 2024
Summary
- As of March 10, 2025, VYNE annual stockholders equity is $52.09 million, with the most recent change of -$36.65 million (-41.30%) on December 31, 2024.
- During the last 3 years, VYNE annual shareholders equity has risen by +$3.45 million (+7.09%).
- VYNE annual shareholders equity is now -60.05% below its all-time high of $130.38 million, reached on December 31, 2018.
Performance
VYNE Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$52.09 M
-$11.45 M-18.02%
December 1, 2024
Summary
- As of March 10, 2025, VYNE quarterly stockholders equity is $52.09 million, with the most recent change of -$11.45 million (-18.02%) on December 1, 2024.
- Over the past year, VYNE quarterly shareholders equity has stayed the same.
- VYNE quarterly shareholders equity is now -68.57% below its all-time high of $165.70 million, reached on March 31, 2018.
Performance
VYNE Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
VYNE Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -41.3% | 0.0% |
| 3 y3 years | +7.1% | 0.0% |
| 5 y5 years | -24.0% | 0.0% |
VYNE Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -41.3% | +66.9% | -41.3% | +352.7% |
| 5 y | 5-year | -41.3% | +66.9% | -43.9% | +352.7% |
| alltime | all time | -60.0% | +191.3% | -68.6% | +191.3% |
VYNE Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $52.09 M(-41.3%) | - |
| Dec 2024 | - | $52.09 M(-18.0%) |
| Sep 2024 | - | $63.54 M(-15.1%) |
| Jun 2024 | - | $74.87 M(-10.2%) |
| Mar 2024 | - | $83.37 M(-6.0%) |
| Dec 2023 | $88.73 M(+184.4%) | $88.73 M(+671.3%) |
| Sep 2023 | - | $11.51 M(-33.4%) |
| Jun 2023 | - | $17.27 M(-34.7%) |
| Mar 2023 | - | $26.43 M(-15.3%) |
| Dec 2022 | $31.20 M(-35.8%) | $31.20 M(-22.1%) |
| Sep 2022 | - | $40.07 M(-17.1%) |
| Jun 2022 | - | $48.36 M(-13.2%) |
| Mar 2022 | - | $55.73 M(+14.6%) |
| Dec 2021 | $48.64 M | $48.64 M(-17.4%) |
| Sep 2021 | - | $58.89 M(-21.4%) |
| Jun 2021 | - | $74.89 M(-19.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $92.90 M(+147.8%) |
| Dec 2020 | $37.49 M(-45.3%) | $37.49 M(-24.3%) |
| Sep 2020 | - | $49.52 M(-30.8%) |
| Jun 2020 | - | $71.53 M(+2.9%) |
| Mar 2020 | - | $69.53 M(+1.5%) |
| Dec 2019 | $68.51 M(-47.5%) | $68.51 M(-21.3%) |
| Sep 2019 | - | $87.00 M(-14.9%) |
| Jun 2019 | - | $102.18 M(-11.6%) |
| Mar 2019 | - | $115.63 M(-11.3%) |
| Dec 2018 | $130.38 M(-328.6%) | $130.38 M(-11.2%) |
| Sep 2018 | - | $146.88 M(-7.1%) |
| Jun 2018 | - | $158.19 M(-4.5%) |
| Mar 2018 | - | $165.70 M(-390.5%) |
| Dec 2017 | -$57.03 M(+93.7%) | -$57.03 M(+18.9%) |
| Sep 2017 | - | -$47.96 M(+62.9%) |
| Dec 2016 | -$29.44 M(+84.5%) | -$29.44 M |
| Dec 2015 | -$15.95 M | - |
FAQ
- What is VYNE Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for VYNE Therapeutics?
- What is VYNE Therapeutics annual shareholders equity year-on-year change?
- What is VYNE Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for VYNE Therapeutics?
- What is VYNE Therapeutics quarterly shareholders equity year-on-year change?
What is VYNE Therapeutics annual stockholders equity?
The current annual shareholders equity of VYNE is $52.09 M
What is the all time high annual shareholders equity for VYNE Therapeutics?
VYNE Therapeutics all-time high annual stockholders equity is $130.38 M
What is VYNE Therapeutics annual shareholders equity year-on-year change?
Over the past year, VYNE annual stockholders equity has changed by -$36.65 M (-41.30%)
What is VYNE Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of VYNE is $52.09 M
What is the all time high quarterly shareholders equity for VYNE Therapeutics?
VYNE Therapeutics all-time high quarterly stockholders equity is $165.70 M
What is VYNE Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, VYNE quarterly stockholders equity has changed by $0.00 (0.00%)